Drug & intervention
carmustine
RxCUI 2105
RxNorm ingredient and formulation relationships
Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.
Loading RxNorm relationships…
Background context
Carmustine
Carmustine, sold under the brand name BiCNU among others, is a medication used mainly for chemotherapy. It is a nitrogen mustard β-chloro-nitrosourea compound used as an alkylating agent.
Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.Clinical trials
13 shownAutologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment for Triple Negative Breast Cancer PatientsNCT02670109 · 2018-02-01
UNKNOWNHIV-Resistant Gene Modified Stem Cells and Chemotherapy in Treating Patients With Lymphoma With HIV InfectionNCT02343666 · 2016-08-15
WITHDRAWNGene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell TransplantNCT02797470 · 2016-06-23
ACTIVE_NOT_RECRUITINGGenetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin LymphomaNCT01769911 · 2015-02-01
WITHDRAWNAutologous Stem Cell Transplant for Neurologic Autoimmune DiseasesNCT00716066 · 2008-06-01
ACTIVE_NOT_RECRUITINGGene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related LymphomaNCT00569985 · 2007-06-01
COMPLETEDAutologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's LymphomaNCT00345865 · 2005-08-24
COMPLETEDChemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast CancerNCT00006123 · 2000-07-01
WITHDRAWNCarmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated LymphomaNCT00641381 · 2000-05-10
COMPLETEDCombination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate CancerNCT00003400 · 1998-09-01
COMPLETEDS9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast CancerNCT00002772 · 1996-07-01
TERMINATEDFilgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast CancerNCT00002836 · 1995-09-26
COMPLETEDHigh-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid TumorsNCT00060255 · 1991-12-01
COMPLETEDConditions being studied
Breast Cancer4Lymphoma4Recurrent Adult Hodgkin Lymphoma2Adult Nasal Type Extranodal NK/T-cell Lymphoma1AIDS-related Diffuse Large Cell Lymphoma1AIDS-related Diffuse Mixed Cell Lymphoma1AIDS-related Diffuse Small Cleaved Cell Lymphoma1AIDS-related Immunoblastic Large Cell Lymphoma1AIDS-related Lymphoblastic Lymphoma1AIDS-related Peripheral/Systemic Lymphoma1AIDS-related Small Noncleaved Cell Lymphoma1Anaplastic Large Cell Lymphoma1Angioimmunoblastic T-cell Lymphoma1Autoimmune Disease1Autoimmune Nervous System Disorder1Autologous Transplant Autoimmune1Central Nervous System Vasculitis1Cerebellar Degeneration1Chronic Inflammatory Demyelinating Polyneuropathy1CIDP Transplant1
Research locations
SeattleWashington, United States3DuarteCalifornia, United States2New YorkNew York, United States2BaltimoreMaryland, United States1BostonMassachusetts, United States1BuffaloNew York, United States1DenverColorado, United States1HackensackNew Jersey, United States1HoustonTexas, United States1La JollaCalifornia, United States1Mexico CityMexico City, Mexico1MinneapolisMinnesota, United States1
Leading sponsors
Fred Hutchinson Cancer Center3City of Hope Medical Center2AIDS Malignancy Consortium1Beth Israel Deaconess Medical Center1Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran1M.D. Anderson Cancer Center1Masonic Cancer Center, University of Minnesota1Roswell Park Cancer Institute1SWOG Cancer Research Network1University of Maryland, Baltimore1
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.